Target intelligence / Profile preview

Transient receptor potential cation channel subfamily V member 3 (TRPV3) (TRPV3)

Target
TRPV3
Molecular classification
Ion channel, Transient receptor potential channel, Cation channel
01

Overview

Transient receptor potential cation channel subfamily V member 3 (TRPV3) is a non-selective cation channel primarily expressed in the keratinocytes of the skin, as well as in the brain and spinal cord (UniProt, 2024). It functions as a polymodal sensor activated by warm temperatures (typically >33°C), various botanical compounds like camphor and carvacrol, and endogenous lipids (PubMed, 2022). TRPV3 plays a pivotal role in skin health, regulating epidermal differentiation, hair follicle development, and wound healing (NCBI, 2023). Gain-of-function mutations in the TRPV3 gene are the primary cause of Olmsted syndrome, a rare disorder characterized by severe palmoplantar keratoderma and intense pruritus (NIH, 2021). Due to its involvement in itch and inflammatory pathways, TRPV3 is a significant therapeutic target for conditions such as atopic dermatitis and chronic pruritus, with several antagonists having entered clinical development (PubChem, 2024). Pharmacological modulation of this channel offers a promising approach for treating dermatological diseases where barrier function and sensory signaling are compromised (StatPearls, 2023). Research also suggests its involvement in broader physiological processes such as systemic thermoregulation and nociceptive signaling in the peripheral nervous system (PubMed, 2021).

Other names
VRL3Vanilloid receptor-like protein 3TRP-V3
02

Mechanism of action

TRPV3 modulators primarily function as antagonists to block the overactive cation influx associated with inflammatory skin conditions and chronic itch, or as agonists to stimulate hair growth and study thermosensory pathways.

03

Biological functions

ThermosensationSkin barrier maintenanceHair growthWound healingNociceptionPruritus
04

Disease associations

Olmsted syndromeAtopic dermatitisPsoriasisPruritusKeratodermaInflammation
05

Safety considerations

Potential for hyperthermia or impaired thermoregulationRisk of skin barrier disruptionAlterations in thermal sensitivity
06

Interacting drugs

GRC-15300

7 more in the full profile.

07

Biomarkers

TRPV3 protein expression in skin biopsiesInterleukin-31 (IL-31) levelsThymic stromal lymphopoietin (TSLP) levels

Beyond the preview

Go deeper on Transient receptor potential cation channel subfamily V member 3 (TRPV3) (TRPV3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transient receptor potential cation channel subfamily V member 3 (TRPV3) (TRPV3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call